A class of 2-aryloxy-2-arylalkanoic acids comprises compounds that are
potent agonists of PPAR alpha and/or gamma, and are therefore useful in
the treatment, control or prevention of non-insulin dependent diabetes
mellitus (NIDDM), hyperglycemia, dyslipidemia, hyperlipidemia,
hypercholesterolemia, hypertriglyceridemia, atherosclerosis, obesity,
vascular restenosis, inflammation, and other PPAR alpha and/or gamma
mediated diseases, disorders and conditions.